Vitamin A for Immune Function

Verdict: Works for deficient children, harmful for smokers

Vitamin A's effect on immunity depends entirely on who takes it: high-dose supplementation sharply cuts death and measles severity in vitamin-A-deficient children, but it provides no proven immune benefit in well-nourished adults and raises lung-cancer risk in smokers. There is no good evidence it "boosts immunity" in healthy, replete people.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

The grade is Weak/Disputed because the evidence is high-quality but splits sharply by population rather than pointing one way. In deficient children the signal is strong: an Imdad 2017 Cochrane review (PMID 28282701, ~1.2 million children) found all-cause mortality RR 0.88 and measles incidence RR 0.50, the foundational Sommer 1986 Indonesian trial (PMID 2871418) cut child deaths ~34%, and a measles-treatment Cochrane review (PMID 15495002) lowered measles mortality RR 0.39. WHO accordingly gives a rare strong recommendation, but only where deficiency is endemic.

The counter-evidence is what holds the grade down. In smokers and asbestos-exposed workers, the CARET trial (PMID 8602180) raised lung-cancer risk (RR 1.28) and was stopped early for harm, and the ATBC trial (PMID 8127329) found an 18% increase (RR 1.18). Benefit also fades where deficiency is uncommon: the ~1-million-child DEVTA trial (PMID 18502287) showed a non-significant RR 0.96, and in HIV-positive pregnant women vitamin A gave no benefit and possibly increased transmission (PMID 9605804).

Regulators and clinics mirror this nuance. EFSA permits only a modest 'contributes to normal immune function' claim, while NHS warns against retinol supplements in pregnancy, and Cleveland Clinic and Harvard stress that most people get enough from food and that 'more is not better' — explicitly flagging cancer risk in smokers. For a typical well-nourished adult seeking an immune boost, the evidence does not support supplementing, and for smokers it warns against it.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.49
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
80%
Broadly consistent
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L5 Clinical bodiesAuthoritative stance
0.52
L11 AI re-checkIndependent read
0.65
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.492
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (7)L2 · primary research & systematic reviews

Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
PMID: 28282701 2017 Cochrane SR n = 1,202,382
Finding: Imdad et al. updated Cochrane review of 47 trials (19 mortality trials; 1,202,382 children). Vitamin A supplementation (VAS) reduced all-cause mortality RR 0.88 (95% CI 0.83-0.93; high-certainty evidence), diarrhoea-specific mortality RR 0.88 (95% CI 0.79-0.98), and measles incidence RR 0.50 (95% CI 0.37-0.67). No significant effect on respiratory mortality. Authors conclude VAS clearly reduces mortality and measles morbidity in children 6-59 months in vitamin-A-deficient settings — one of the strongest public-health micronutrient interventions on record.
🟢 High quality Academic Effect size: [object Object]
View on PubMed
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
PMID: 8602180 1996 RCT (double-blind) n = 18,314
Finding: Omenn et al. (CARET, NEJM 1996) RCT in 18,314 high-risk individuals (smokers/asbestos workers). β-carotene + retinyl palmitate INCREASED lung cancer incidence RR 1.28 (95% CI 1.04-1.57, p=0.02), all-cause mortality RR 1.17 (95% CI 1.03-1.33), and cardiovascular mortality RR 1.26 (95% CI 0.99-1.61). Trial was stopped 21 months early due to harm signal. Critical counter-evidence: in current smokers, pre-formed vitamin A / β-carotene supplementation is HARMFUL, not protective — directly opposite to the deficiency-context benefit.
🟢 High quality Government Effect size: [object Object]
View on PubMed
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers (ATBC)
PMID: 8127329 1994 RCT (double-blind) n = 29,133
Finding: ATBC Cancer Prevention Study Group (NEJM 1994) RCT in 29,133 male smokers. β-carotene arm showed 18% INCREASE in lung cancer incidence (RR 1.18, 95% CI 1.03-1.36) and 8% increase in total mortality (RR 1.08, 95% CI 1.01-1.16). No protective effect of α-tocopherol on lung cancer. Combined with CARET, established the modern consensus that β-carotene supplementation in smokers is contraindicated — a foundational harm-signal trial reshaping antioxidant chemoprevention policy.
🟢 High quality Government Effect size: [object Object]
View on PubMed
Impact of vitamin A supplementation on childhood mortality. A randomised controlled community trial
PMID: 2871418 1986 隨機對照試驗 n = 25,939
Finding: Sommer et al. (Lancet 1986) cluster-RCT in 450 villages in Aceh, Indonesia, covering 25,939 preschool children. Mortality 34% lower in supplemented villages (RR ~0.66). Foundational trial establishing that periodic high-dose vitamin A could substantially reduce child mortality in deficient populations — directly motivated WHO global VAS policy and subsequent Nepal/Ghana/India trials. Effect concentrated in children >12 months with clinical or sub-clinical xerophthalmia.
🟢 High quality Government Effect size: [object Object]
View on PubMed
Vitamin A for treating measles in children
PMID: 15495002 2005 Cochrane SR n = 2,069
Finding: Huiming, Chaomin, Meng (updated by D'Souza & D'Souza) Cochrane review. Two-dose high-dose vitamin A (200,000 IU x 2 days) reduced overall measles mortality RR 0.39 (95% CI 0.20-0.78) and pneumonia-specific mortality RR 0.33 (95% CI 0.15-0.74) in children under 2 years. No effect in older children. WHO recommends 2-dose VAS as standard of care for all children with measles in endemic areas. Strong therapeutic-context support.
🟢 High quality Academic Effect size: [object Object]
View on PubMed
Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania
PMID: 9605804 1999 RCT (double-blind) n = 1,075
Finding: Fawzi et al. (Lancet 1998/1999) RCT in 1075 HIV-positive Tanzanian pregnant women. Multivitamins (B/C/E) reduced low birth weight and prematurity. Vitamin A alone showed NO benefit on pregnancy outcomes and in subsequent analyses (Fawzi 2002) was associated with INCREASED mother-to-child HIV transmission risk in some sub-strata. This trial — together with PETRA and ZVITAMBO — led WHO to NOT recommend antenatal vitamin A for HIV-positive women specifically.
🟢 High quality Government
View on PubMed
Neonatal vitamin A supplementation and infant survival in Asia
PMID: 18502287 2008 隨機對照試驗 n = 1,000,000
Finding: Awasthi et al. (DEVTA, Lancet 2013 — registered 2011) Indian cluster-RCT of ~1 million preschoolers. Mortality reduction only 4% (RR 0.96, 95% CI 0.89-1.03), much smaller than historical Indonesia/Nepal trials and not statistically significant. Triggered re-examination of WHO VAS policy: in populations where baseline vitamin A deficiency has declined and measles coverage is high, the marginal mortality benefit may have diminished. Imdad 2017 Cochrane pooled DEVTA and still found RR 0.88 overall.
🟢 High quality Government Effect size: [object Object]
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
Vitamin A — GRAS — 21 CFR 184.1245, 184.1930 — Technical Effect: NUTRIENT SUPPLEMENT — SCOGS no. 118 source↗
L4b EU EFSA
Neutral
Vitamin A contributes to the normal function of the immune system; Vitamin A contributes to the maintenance of normal vision; Vitamin A contributes to the maintenance of normal skin; Vitamin A contributes to the maintenance of normal mucous membranes; Vitamin A has a role in the process of cell specialisation; Vitamin A contributes to normal iron metabolism. source↗
L4c UK NHS
Cautious
Do not take cod liver oil or any supplements containing vitamin A (retinol) when you're pregnant. Too much vitamin A could harm your baby. source↗
L4d TW TFDA / 衛福部
Neutral
維生素A 指示藥每日用量上限 10,000 IU(3,000 微克 RE);換算:1 微克 RE = 1 微克 Retinol = 6 微克 β-Carotene;3 微克 RE = 10 IU。 source↗
L4e WHO
Supportive
In settings where vitamin A deficiency is a public health problem, vitamin A supplementation is recommended in infants and children 6-59 months of age as a public health intervention to reduce child morbidity and mortality (strong recommendation). source↗
L5a NIH Office of Dietary Supplements
Supportive
The most common clinical sign of vitamin A deficiency is xerophthalmia, which develops after plasma retinol has been low. The first sign is night blindness, or the inability to see in low light or darkness as a result of low rhodopsin levels in the retina. source↗
L5c Cleveland Clinic
Neutral
Vitamin A strengthens your immune system by supporting white blood cells and the mucus membranes in your lungs, intestines and urinary tract. source↗
L5d Harvard Health
Cautious
deficiencies of zinc, selenium, iron, copper, folic acid, and vitamins A, B6, C, and E — alter cellular immune responses. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬7 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-immune-function-INT-vitamin-a-001 繁體中文版 →